Walleye Trading
AMED

Walleye Trading’s Amedisys AMED Stock Holding History

Walleye Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,100
Closed -$3.75M – 4335
2025
Q2 		$3.75M Sell
38,100
-5,000
-12% -$473K 0.01% 1364
2025
Q1 		$3.99M Buy
43,100
+1,500
+4% +$138K 0.01% 1223
2024
Q4 		$3.78M Sell
41,600
-18,000
-30% -$1.65M 0.01% 1331
2024
Q3 		$5.75M Hold
59,600
– – 0.01% 1058
2024
Q2 		$5.47M Sell
59,600
-200
-0.3% -$18.6K 0.01% 1017
2024
Q1 		$5.51M Buy
59,800
+100
+0.2% +$9.37K 0.01% 1059
2023
Q4 		$5.68M Buy
59,700
+53,100
+805% +$4.96M 0.01% 1169
2023
Q3 		$616K Sell
6,600
-8,400
-56% -$776K ﹤0.01% 2771
2023
Q2 		$1.37M Buy
15,000
+13,200
+733% +$1.08M ﹤0.01% 1924
2023
Q1 		$132K Buy
+1,800
New +$156K ﹤0.01% 3733
2022
Q3 		– Sell
-8,900
Closed -$936K – 4987
2022
Q2 		$936K Sell
8,900
-6,600
-43% -$843K ﹤0.01% 2282
2022
Q1 		$2.67M Buy
15,500
+13,700
+761% +$2.05M 0.01% 1449
2021
Q4 		$291K Buy
+1,800
New +$289K ﹤0.01% 3499
2021
Q3 		– Sell
-2,500
Closed -$612K – 5164
2021
Q2 		$612K Hold
2,500
– – ﹤0.01% 2671
2021
Q1 		$662K Buy
2,500
+2,400
+2,400% +$677K ﹤0.01% 2326
2020
Q4 		$29K Sell
100
-4,900
-98% -$1.26M ﹤0.01% 4319
2020
Q3 		$1.18M Sell
5,000
-1,100
-18% -$250K 0.01% 1528
2020
Q2 		$1.21M Buy
6,100
+5,000
+455% +$933K 0.01% 1490
2020
Q1 		$202K Sell
1,100
-300
-21% -$53.4K ﹤0.01% 2585
2019
Q4 		$234K Sell
1,400
-3,800
-73% -$565K ﹤0.01% 3044
2019
Q3 		$681K Sell
5,200
-1,100
-17% -$143K 0.01% 1886
2019
Q2 		$765K Buy
6,300
+5,100
+425% +$605K 0.01% 1813
2019
Q1 		$148K Sell
1,200
-6,300
-84% -$791K ﹤0.01% 3239
2018
Q4 		$878K Sell
7,500
-4,500
-38% -$530K 0.01% 1860
2018
Q3 		$1.5M Sell
12,000
-9,300
-44% -$1.03M 0.01% 1640
2018
Q2 		$1.82M Sell
21,300
-4,000
-16% -$294K 0.01% 1450
2018
Q1 		$1.53M Buy
+25,300
New +$1.44M 0.01% 1486
2017
Q4 		– Sell
-6,200
Closed -$348 – 4296
2017
Q3 		$348 Sell
6,200
-3,100
-33% -$164K ﹤0.01% 2791
2017
Q2 		$585 Sell
9,300
-28,200
-75% -$1.64M ﹤0.01% 2234
2017
Q1 		$1.92K Buy
37,500
+36,400
+3,309% +$1.74M 0.01% 1126
2016
Q4 		$46K Sell
1,100
-10,400
-90% -$442K ﹤0.01% 3684
2016
Q3 		$546K Sell
11,500
-500
-4% -$25K ﹤0.01% 2063
2016
Q2 		$605K Buy
12,000
+4,200
+54% +$212K ﹤0.01% 2041
2016
Q1 		$378K Sell
7,800
-6,000
-43% -$232K ﹤0.01% 2213
2015
Q4 		$544K Buy
13,800
+8,900
+182% +$356K 0.01% 1784
2015
Q3 		$186K Buy
4,900
+100
+2% +$4.22K ﹤0.01% 2415
2015
Q2 		$191K Buy
4,800
+400
+9% +$12.5K ﹤0.01% 2521
2015
Q1 		$118K Sell
4,400
-7,200
-62% -$203K ﹤0.01% 2561
2014
Q4 		$340K Buy
11,600
+3,200
+38% +$79K ﹤0.01% 1893
2014
Q3 		$169K Buy
8,400
+2,000
+31% +$38.6K ﹤0.01% 2202
2014
Q2 		$108 Buy
6,400
+2,800
+78% +$39.7K ﹤0.01% 2423
2014
Q1 		$53 Sell
3,600
-400
-10% -$6.16K ﹤0.01% 2690
2013
Q4 		$58K Sell
4,000
-16,500
-80% -$266K ﹤0.01% 2766
2013
Q3 		$352K Buy
+20,500
New +$304K ﹤0.01% 1402

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's AMED Position: Q2 2023 in Review

Walleye Trading sold out of Amedisys (AMED) in Q2 2023, closing a stake of 7,814 shares — an estimated $641K sold.

Walleye Trading first reported a position in AMED in Q3 2015 and held it in 18 quarters. The position peaked at $826K in Q4 2018. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Walleye Trading reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 7,814 Amedisys shares in Q2 2023, an estimated $641K.
  • Walleye Trading first reported a position in Amedisys in Q3 2015 and held it in 18 quarters.
  • Walleye Trading's Amedisys position peaked at $826K in Q4 2018.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.